Literature DB >> 10022527

Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA.

O Zelphati1, X Liang, P Hobart, P L Felgner.   

Abstract

We describe an effective approach using a peptide nucleic acid (PNA) "clamp" to directly and irreversibly modify plasmid DNA, without affecting either its supercoiled conformation or its ability to be efficiently transcribed. To demonstrate this approach a highly fluorescent preparation of plasmid DNA was generated by hybridizing a fluorescently labeled PNA to the plasmid. Fluorescent plasmid prepared in this way was neither functionally nor conformationally altered. PNA binding was sequence specific, saturable, extremely stable, and did not influence the nucleic acid intracellular distribution. This method was utilized for the first time to study the biodistribution of conformationally and functionally intact plasmid DNA in living cells after cationic lipid-mediated transfection. A fluorescent plasmid expressing green fluorescent protein (GFP) enabled simultaneous colocalization of both plasmid and expressed protein in living cells and in real time. GFP was shown to be expressed in cells containing detectable nuclear fluorescent plasmid. The fluorescent PNA-labeled plasmid revealed a marked difference in the nuclear uptake between oligonucleotide and plasmid, suggesting that nuclear entry of plasmid may require cell division. This detection method provides a way to simultaneously monitor the intracellular localization and expression of plasmid DNA in living cells, and to elucidate the mechanism of plasmid delivery and its nuclear import with synthetic gene delivery systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022527     DOI: 10.1089/10430349950019156

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  23 in total

1.  Nuclear import of plasmid DNA in digitonin-permeabilized cells requires both cytoplasmic factors and specific DNA sequences.

Authors:  G L Wilson; B S Dean; G Wang; D A Dean
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

3.  Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA.

Authors:  Kirsten M L Hertoghs; Jonathan H Ellis; Ian R Catchpole
Journal:  Nucleic Acids Res       Date:  2003-10-15       Impact factor: 16.971

Review 4.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

5.  Structural and functional consequences of poly(ethylene glycol) inclusion on DNA condensation for gene delivery.

Authors:  Peter G Millili; Joshua A Selekman; Kory M Blocker; David A Johnson; Ulhas P Naik; Millicent O Sullivan
Journal:  Microsc Res Tech       Date:  2010-09       Impact factor: 2.769

Review 6.  Intracellular trafficking of nucleic acids.

Authors:  Rui Zhou; R Christopher Geiger; David A Dean
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 7.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

8.  Postmitotic nuclear retention of episomal plasmids is altered by DNA labeling and detection methods.

Authors:  Joshua Z Gasiorowski; David A Dean
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

Review 9.  Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.

Authors:  Erin E Vaughan; James V DeGiulio; David A Dean
Journal:  Curr Gene Ther       Date:  2006-12       Impact factor: 4.391

10.  Padlock oligonucleotides as a tool for labeling superhelical DNA.

Authors:  Thibaut Roulon; Dominique Coulaud; Etienne Delain; Eric Le Cam; Claude Hélène; Christophe Escudé
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.